Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Ellis

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Endocrine-Related Cancer|March 25, 2000
Clinical studies of apoptosis and proliferation in breast cancerM Dowsett, C Archer, L Assersohn, et al.
International Journal of Cancer|August 7, 1997
Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancerP A Ellis, G Saccani-Jotti, R Clarke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2007
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancerR Rosell, G Robinet, A Szczesna, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|May 5, 2011
The challenges of integrating molecular imaging into the optimization of cancer therapyG S Patel, T Kiuchi, K Lawler, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Endocrine-Related Cancer|March 25, 2000
Clinical studies of apoptosis and proliferation in breast cancerM Dowsett, C Archer, L Assersohn, et al.
International Journal of Cancer|August 7, 1997
Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancerP A Ellis, G Saccani-Jotti, R Clarke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2007
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancerR Rosell, G Robinet, A Szczesna, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|May 5, 2011
The challenges of integrating molecular imaging into the optimization of cancer therapyG S Patel, T Kiuchi, K Lawler, et al.
Pageof 5